Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$191.17 - $325.63 $2,867 - $4,884
15 Added 0.38%
4,003 $1.3 Million
Q4 2023

Jan 19, 2024

SELL
$160.99 - $215.69 $61,176 - $81,962
-380 Reduced 8.7%
3,988 $759,000
Q3 2023

Oct 16, 2023

SELL
$194.33 - $283.97 $34,007 - $49,694
-175 Reduced 3.85%
4,368 $869,000
Q2 2023

Jul 24, 2023

SELL
$223.05 - $302.68 $98,142 - $133,179
-440 Reduced 8.83%
4,543 $1.3 Million
Q1 2023

Apr 17, 2023

SELL
$175.41 - $217.92 $12,629 - $15,690
-72 Reduced 1.42%
4,983 $1.08 Million
Q4 2022

Jan 11, 2023

BUY
$204.38 - $296.82 $14,306 - $20,777
70 Added 1.4%
5,055 $1.04 Million
Q3 2022

Oct 20, 2022

SELL
$195.21 - $310.53 $30,257 - $48,132
-155 Reduced 3.02%
4,985 $1.39 Million
Q2 2022

Jul 08, 2022

BUY
$115.91 - $214.48 $595,777 - $1.1 Million
5,140 New
5,140 $982,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.